SC
AXNX

Scholtz & Company’s Axonics, Inc. Common Stock AXNX Stock Holding History

Scholtz & Company’s Portfolio AXNX Stock Details AXNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-4,985
Closed -$310K – 71
2023
Q4 		$310K Buy
4,985
+360
+8% +$20.1K 0.15% 58
2023
Q3 		$260K Buy
+4,625
New +$260K 0.17% 36

Other funds holding AXNX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Scholtz & Company's AXNX Position: Q1 2024 in Review

Scholtz & Company sold out of Axonics, Inc. Common Stock (AXNX) in Q1 2024, closing a stake of 4,985 shares — an estimated $310K sold.

Scholtz & Company first reported a position in AXNX in Q3 2023 and held it in 2 quarters. The position peaked at $310K in Q4 2023. 235 funds tracked by Wall St. Rank hold AXNX as of Q1 2024.

  • Scholtz & Company reported no remaining Axonics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Scholtz & Company sold 4,985 Axonics, Inc. Common Stock shares in Q1 2024, an estimated $310K.
  • Scholtz & Company first reported a position in Axonics, Inc. Common Stock in Q3 2023 and held it in 2 quarters.
  • Scholtz & Company's Axonics, Inc. Common Stock position peaked at $310K in Q4 2023.
  • 235 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q1 2024.

Based on Scholtz & Company's 13F filing for Q1 2024, filed 14 May 2024.